Used primarily in solid-phase peptide synthesis, this chiral building block enables the incorporation of a cyclopropyl-modified amino acid residue into peptide chains. The Fmoc group allows for mild, base-labile protection of the amine, compatible with Fmoc-strategy protocols. Its cyclopropyl side chain imparts conformational rigidity, making it valuable in the design of peptidomimetics and bioactive peptides with enhanced metabolic stability and receptor selectivity. Commonly employed in pharmaceutical research and development of enzyme inhibitors or receptor ligands where steric and electronic effects of the cyclopropyl group modulate biological activity.